US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 31.540
  • +0.600+1.94%
Close May 8 16:00 ET
  • 31.540
  • 0.0000.00%
Post 16:05 ET
1.77BMarket Cap28.47P/E (TTM)

Supernus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
Operating revenue
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
Cost of revenue
-3.35%15.76M
-7.01%77.91M
32.97%26.1M
-10.30%17.58M
-15.05%17.92M
-30.48%16.31M
-3.95%83.78M
-14.49%19.63M
-24.26%19.6M
3.10%21.09M
Gross profit
5.28%134.06M
11.49%583.91M
2.33%148.06M
17.74%158.11M
31.39%150.41M
-2.28%127.34M
-9.70%523.74M
0.22%144.69M
-11.35%134.28M
-23.48%114.47M
Operating expense
3.86%136.66M
-0.39%508.36M
0.48%126.3M
-6.57%118.28M
0.71%132.2M
3.79%131.58M
-4.50%510.34M
11.79%125.7M
-16.99%126.6M
-4.54%131.27M
Selling and administrative expenses
3.96%89.94M
-4.39%321.58M
-2.30%79.41M
-15.66%69.75M
-1.01%85.9M
1.07%86.52M
-10.83%336.36M
9.88%81.28M
-26.37%82.7M
-13.63%86.78M
-Selling and marketing expense
6.23%63.28M
-0.83%227.29M
-1.24%54.59M
-4.33%54.33M
-1.82%58.8M
4.08%59.57M
--229.19M
--55.28M
-33.74%56.79M
-18.60%59.89M
-General and administrative expense
-1.05%26.67M
-12.02%94.29M
-4.57%24.82M
-40.48%15.42M
0.79%27.1M
-5.00%26.95M
--107.18M
--26.01M
-2.61%25.92M
-0.03%26.89M
Research and development costs
8.01%26.93M
18.78%108.8M
22.70%28.65M
28.17%29.04M
7.40%26.18M
17.53%24.93M
22.86%91.59M
31.35%23.35M
15.86%22.66M
48.79%24.38M
Depreciation amortization depletion
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
-Depreciation and amortization
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
Operating profit
38.89%-2.6M
463.72%75.56M
14.60%21.76M
418.47%39.83M
208.44%18.21M
-220.37%-4.25M
-70.62%13.4M
-40.53%18.99M
840.79%7.68M
-238.94%-16.8M
Net non-operating interest income expense
30.30%4.43M
101.59%16.2M
150.60%4.98M
134.04%4.1M
711.52%3.73M
-11.59%3.4M
-45.02%8.04M
146.40%1.99M
62.28%1.75M
2,190.91%460K
Non-operating interest income
30.30%4.43M
55.02%16.2M
150.60%4.98M
134.04%4.1M
172.48%3.73M
-36.48%3.4M
-51.81%10.45M
-17.25%1.99M
-37.53%1.75M
-23.38%1.37M
Non-operating interest expense
----
--0
--0
--0
--0
--0
-65.84%2.42M
--0
--0
-49.72%910K
Other net income (expense)
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
Special income (charges)
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
-Less：Restructuring and merger&acquisition
799.54%7.66M
-302.77%-6.11M
274.51%356K
-122.81%-1.02M
-651.27%-4.36M
33.52%-1.1M
-197.45%-1.52M
91.51%-204K
-193.83%-456K
6.33%790K
-Less:Impairment of capital assets
----
--0
----
----
----
----
--20.19M
----
----
----
Income before tax
-2,499.59%-5.83M
3,434.49%97.87M
2,564.85%26.38M
354.47%44.94M
253.57%26.3M
-97.31%243K
-95.44%2.77M
-97.18%990K
2,327.25%9.89M
-251.25%-17.13M
Income tax
4,938.66%6M
1,552.10%24.01M
6,075.14%11.05M
-75.08%6.45M
139.19%6.39M
101.50%119K
4,440.63%1.45M
-101.92%-185K
1,279.43%25.87M
-571.12%-16.3M
Net income
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
Net income continuous Operations
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
Minority interest income
Net income attributable to the parent company
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
Basic earnings per share
-0.21
6,600.00%1.34
1,507.99%0.28
341.38%0.7
1,900.00%0.36
0
-98.23%0.02
-96.30%0.0174
-1,066.67%-0.29
-113.33%-0.02
Diluted earnings per share
-0.21
6,500.00%1.32
1,450.57%0.27
337.93%0.69
1,900.00%0.36
0
-98.08%0.02
-95.95%0.0174
-1,066.67%-0.29
-114.29%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M
Operating revenue 4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M
Cost of revenue -3.35%15.76M-7.01%77.91M32.97%26.1M-10.30%17.58M-15.05%17.92M-30.48%16.31M-3.95%83.78M-14.49%19.63M-24.26%19.6M3.10%21.09M
Gross profit 5.28%134.06M11.49%583.91M2.33%148.06M17.74%158.11M31.39%150.41M-2.28%127.34M-9.70%523.74M0.22%144.69M-11.35%134.28M-23.48%114.47M
Operating expense 3.86%136.66M-0.39%508.36M0.48%126.3M-6.57%118.28M0.71%132.2M3.79%131.58M-4.50%510.34M11.79%125.7M-16.99%126.6M-4.54%131.27M
Selling and administrative expenses 3.96%89.94M-4.39%321.58M-2.30%79.41M-15.66%69.75M-1.01%85.9M1.07%86.52M-10.83%336.36M9.88%81.28M-26.37%82.7M-13.63%86.78M
-Selling and marketing expense 6.23%63.28M-0.83%227.29M-1.24%54.59M-4.33%54.33M-1.82%58.8M4.08%59.57M--229.19M--55.28M-33.74%56.79M-18.60%59.89M
-General and administrative expense -1.05%26.67M-12.02%94.29M-4.57%24.82M-40.48%15.42M0.79%27.1M-5.00%26.95M--107.18M--26.01M-2.61%25.92M-0.03%26.89M
Research and development costs 8.01%26.93M18.78%108.8M22.70%28.65M28.17%29.04M7.40%26.18M17.53%24.93M22.86%91.59M31.35%23.35M15.86%22.66M48.79%24.38M
Depreciation amortization depletion -1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M
-Depreciation and amortization -1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M
Operating profit 38.89%-2.6M463.72%75.56M14.60%21.76M418.47%39.83M208.44%18.21M-220.37%-4.25M-70.62%13.4M-40.53%18.99M840.79%7.68M-238.94%-16.8M
Net non-operating interest income expense 30.30%4.43M101.59%16.2M150.60%4.98M134.04%4.1M711.52%3.73M-11.59%3.4M-45.02%8.04M146.40%1.99M62.28%1.75M2,190.91%460K
Non-operating interest income 30.30%4.43M55.02%16.2M150.60%4.98M134.04%4.1M172.48%3.73M-36.48%3.4M-51.81%10.45M-17.25%1.99M-37.53%1.75M-23.38%1.37M
Non-operating interest expense ------0--0--0--0--0-65.84%2.42M--0--0-49.72%910K
Other net income (expense) -799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K
Special income (charges) -799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K
-Less：Restructuring and merger&acquisition 799.54%7.66M-302.77%-6.11M274.51%356K-122.81%-1.02M-651.27%-4.36M33.52%-1.1M-197.45%-1.52M91.51%-204K-193.83%-456K6.33%790K
-Less:Impairment of capital assets ------0------------------20.19M------------
Income before tax -2,499.59%-5.83M3,434.49%97.87M2,564.85%26.38M354.47%44.94M253.57%26.3M-97.31%243K-95.44%2.77M-97.18%990K2,327.25%9.89M-251.25%-17.13M
Income tax 4,938.66%6M1,552.10%24.01M6,075.14%11.05M-75.08%6.45M139.19%6.39M101.50%119K4,440.63%1.45M-101.92%-185K1,279.43%25.87M-571.12%-16.3M
Net income -9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K
Net income continuous Operations -9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K
Minority interest income
Net income attributable to the parent company -9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K
Basic earnings per share -0.216,600.00%1.341,507.99%0.28341.38%0.71,900.00%0.360-98.23%0.02-96.30%0.0174-1,066.67%-0.29-113.33%-0.02
Diluted earnings per share -0.216,500.00%1.321,450.57%0.27337.93%0.691,900.00%0.360-98.08%0.02-95.95%0.0174-1,066.67%-0.29-114.29%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
QIFENG
873169
+29.97%
LAISAI LASER
871263
+26.81%
Hangzhou Wensli Silk Culture
301066
+20.03%
4
Aerospace Nanhu Electronic Information Technology
688552
+20.00%
5
Yoantion Industrial Inc.,
301053
+19.99%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025